FFA
AKTS

Farther Finance Advisors’s Aktis Oncology AKTS Stock Holding History

Farther Finance Advisors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41K Buy
+77
New +$1.58K ﹤0.01% 5107

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's AKTS Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Aktis Oncology (AKTS) in Q2 2026: 77 shares worth $2.41K. The stake represents ﹤0.01% of the portfolio and ranks #5107 among its holdings.

9 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Farther Finance Advisors held 77 shares of Aktis Oncology worth $2.41K as of Q2 2026.
  • Aktis Oncology was a new Farther Finance Advisors position in Q2 2026.
  • Aktis Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5107 holding.
  • 9 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.